Cholinesterase inhibitor
Cholinesterase inhibitors (ChEIs), also known as anti-cholinesterase, are chemicals that prevent the breakdown of the neurotransmitter acetylcholine or butyrylcholine. This increases the amount of the acetylcholine or butyrylcholine in the synaptic cleft that can bind to muscarinic receptors, nicotinic receptors and others. This group of inhibitors is divided into two subgroups, acetylcholinesterase inhibitors (AChEIs) and butyrylcholinesterase inhibitors (BChEIs).
Cholinesterase inhibitor | |
---|---|
Drug class | |
Class identifiers | |
Use | Alzheimer's disease |
ATC code | N06#N06DA Anticholinesterases |
Mechanism of action | Enzyme inhibitor |
Biological target | Cholinesterase |
Clinical data | |
Drugs.com | Drug Classes |
WebMD | MedicineNet |
External links | |
MeSH | D002800 |
Legal status | |
In Wikidata |
ChEIs may be used as drugs for Alzheimer's and myasthenia gravis, and also as chemical weapons and insecticides. Side effects when used as drugs may include loss of appetite, nausea, vomiting, loose stools, vivid dreams at night, dehydration, rash, bradycardia, peptic ulcer disease, seizures, weight loss, rhinorrhea, salivation, muscle cramps, and fasciculations.
ChEIs are indirect-acting parasympathomimetic drugs.
ChEls are widely used as chemical weapons. Since November 2019 the group of ACheIs known as Novichoks have been banned as agents of warfare under the Chemical Weapons Convention. Novichok agents are neurotoxic organophosphorus compounds and are considered more potent than VX gas, also a neurotoxic organophosphorus compound.